Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing nevirapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine- and nevirapine- and zidovudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lamivudine and nevirapine and stavudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nevirapine 400 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to nevirapine |
Causative agent (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nevirapine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine- and nevirapine- and stavudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Nevirapine hemihydrate |
Is a |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nevirapine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Nevirapine 400 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 400 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 200 mg oral tablet |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension |
Has basis of strength substance (attribute) |
False |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine hemihydrate |
Is modification of (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine and nevirapine and stavudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine and nevirapine and zidovudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Nevirapine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only nevirapine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely nevirapine 50 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nevirapine 50 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 10 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 10 mg/mL oral suspension |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 100 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 100 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 50 mg tablet for oral suspension |
Has precise active ingredient |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine 50 mg tablet for oral suspension |
Has basis of strength substance (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nevirapine anhydrous (substance) |
Is modification of (attribute) |
True |
Nevirapine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|